Mesenchymal stromal cells loading curcumin-INVITE-micelles: A drug delivery system for neurodegenerative diseases

Colloids and Surfaces B: Biointerfaces

Volumn 125, Issue , 2015, Pages 300-308

  Tripodo, Giuseppe ^a   Chlapanidas, Theodora ^a   Perteghella, Sara ^a   Vigani, Barbara ^a   Mandracchia, Delia ^b   Trapani, Adriana ^b   Galuzzi, Marta ^a,c   Tosca, Marta Cecilia ^c   Antonioli, Barbara ^c   Gaetani, Paolo ^d   Marazzi, Mario ^c   Torre, Maria Luisa ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Amyotrophic lateral sclerosis (ALS); Curcumin; Inulin; Mesenchymal stromal cells; Vitamin E

Indexed keywords

CELL CULTURE; CELL MEMBRANES; CELLS; CYTOLOGY; DISEASE CONTROL; DRUG DELIVERY; DRUG THERAPY; FLOWCHARTING; HISTOLOGY; HYDROPHOBICITY; MICELLES; NEURODEGENERATIVE DISEASES; POLYSACCHARIDES; TISSUE;

AMYOTROPHIC LATERAL SCLEROSIS; CURCUMIN; INULIN; MESENCHYMAL STROMAL CELLS; VITAMIN-E;

LOADING;

ALPHA TOCOPHEROL; CURCUMIN; DRUG CARRIER; INULIN; INULIN DEXTRO ALPHA TOCOPHEROL SUCCINATE; UNCLASSIFIED DRUG; MICELLE; NEUROPROTECTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL MEMBRANE TRANSPORT; CELL NUCLEUS; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STROMA CELL; MICELLE; ADIPOSE TISSUE; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; KINETICS; METABOLISM; PRIMARY CELL CULTURE; SURGERY;

ADIPOSE TISSUE; ALPHA-TOCOPHEROL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL SURVIVAL; CURCUMIN; DRUG CARRIERS; DRUG LIBERATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INULIN; KINETICS; MESENCHYMAL STROMAL CELLS; MICELLES; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; VITAMIN E;

EID: 84920136726     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.11.034     Document Type: Article

References (48)

1. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F.C., Krause D.S., Deans R.J., Keating A., Prockop D.J., Horwitz E.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
2. de Girolamo L., Lucarelli E., Alessandri G., Avanzini M.A., Bernardo M.E., Biagi E., Brini A.T., D'Amico G., Fagioli F., Ferrero I., Locatelli F., Maccario R., Marazzi M., Parolini O., Pessina A., Torre M.L. G. Italian mesenchymal stem cell, mesenchymal stem/stromal cells: a new cells as drugs paradigm. Efficacy and critical aspects in cell therapy. Curr. Pharm. Des. 2013, 19:2459-2473.
3. Caplan A.I. What's in a name?. Tissue Eng. A 2010, 16:2415-2417.
4. Chapel A., Bertho J.M., Bensidhoum M., Fouillard L., Young R.G., Frick J., Demarquay C., Cuvelier F., Mathieu E., Trompier F., Dudoignon N., Germain C., Mazurier C., Aigueperse J., Borneman J., Gorin N.C., Gourmelon P., Thierry D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med. 2003, 5:1028-1038.
5. Sasaki M., Abe R., Fujita Y., Ando S., Inokuma D., Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 2008, 180:2581-2587.
6. Oliveira-Sales E.B., Maquigussa E., Semedo P., Pereira L.G., Ferreira V.M., Camara N.O., Bergamaschi C.T., Campos R.R., Boim M.A. Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. PLoS ONE 2013, 8.
7. Kim H., Kim H.Y., Choi M.R., Hwang S., Nam K.-H., Kim H.-C., Han J.S., Kim K.S., Yoon H.S., Kim S.H. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci. Lett. 2010, 468:190-194.
8. Thomsen G.M., Gowing G., Svendsen S., Svendsen C.N. The past, present and future of stem cell clinical trials for ALS. Exp. Neurol. 2014, 262:127-137.
9. Meamar R., Nasr-Esfahani M.H., Mousavi S.A., Basiri K. Stem cell therapy in amyotrophic lateral sclerosis. J. Clin. Neurosci. 2013, 20:1659-1663.
10. Soler B., Fadic R., von Bernhardi R. Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view. Rev. Neurol. 2011, 52:426-434.
11. Duchi S., Sotgiu G., Lucarelli E., Ballestri M., Dozza B., Santi S., Guerrini A., Dambruoso P., Giannini S., Donati D., Ferroni C., Varchi G. Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: effective photoinduced in vitro killing of osteosarcoma. J. Control. Release 2013, 168:225-237.
12. Duchi S., Dambruoso P., Martella E., Sotgiu G., Guerrini A., Lucarelli E., Pessina A., Cocce V., Bonomi A., Varchi G. Thiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanes. Bioconj. Chem. 2014, 25:649-655.
13. Mandracchia D., Tripodo G., Latrofa A., Dorati R. Amphiphilic inulin-d-alpha-tocopherol succinate (INVITE) bioconjugates for biomedical applications. Carbohydr. Polym. 2014, 103:46-54.
14. Tripodo G., Mandracchia D., Dorati R., Latrofa A., Genta I., Conti B. Nanostructured polymeric functional micelles for drug delivery applications. Macromol. Symp. 2013, 334:17-23.
15. Pitarresi G., Tripodo G., Triolo D., Fiorica C., Giammona G. Inulin vinyl sulfone derivative cross-linked with bis-amino PEG: new materials for biomedical applications. J. Drug Deliv. Sci. Technol. 2009, 19:419-423.
16. Tripodo G., Pitarresi G., Cavallaro G., Palumbo F.S., Giammona G. Controlled release of IgG by novel UV induced polysaccharide/poly(amino acid) hydrogels. Macromol. Biosci. 2009, 9:393-401.
17. Castelli F., Sarpietro M.G., Micieli D., Ottimo S., Pitarresi G., Tripodo G., Carlisi B., Giammona G. Differential scanning calorimetry study on drug release from an inulin-based hydrogel and its interaction with a biomembrane model: pH and loading effect. Eur. J. Pharm. Sci. 2008, 35:76-85.
18. Pitarresi G., Tripodo G., Calabrese R., Craparo E.F., Licciardi M., Giarnmona G. Hydrogels for potential colon drug release by thiol-ene conjugate addition of a new inulin derivative. Macromol. Biosci. 2008, 8:891-902.
19. Tripodo G., Pitarresi G., Palumbo F.S., Craparo E.F., Giammona G. UV-photocrosslinking of inulin derivatives to produce hydrogels for drug delivery application. Macromol. Biosci. 2005, 5:1074-1084.
20. Mandracchia D., Denora N., Franco M., Pitarresi G., Giammona G., Trapani G. New biodegradable hydrogels based on inulin and alpha,beta-polyaspartylhydrazide designed for colonic drug delivery: in vitro release of glutathione and oxytocin. J. Biomater. Sci. Polym. Ed. 2011, 22:313-328.
21. Pitarresi G., Tripodo G., Cavallaro G., Palumbo F.S., Giammona G. Inulin-iron complexes: a potential treatment of iron deficiency anaemia. Eur. J. Pharm. Biopharm. 2008, 68:267-276.
22. Licciardi M., Scialabba C., Sardo C., Cavallaro G., Giammona G. Amphiphilic inulin graft co-polymers as self-assembling micelles for doxorubicin delivery. J. Mater. Chem. B 2014, 2:4262-4271.
23. Thabet M.A., Chan J.C.M. Vitamin E in renal therapeutic regimens. Pediatr. Nephrol. 2006, 21:1790-1801.
24. Virmani A., Pinto L., Binienda Z., Ali S. Food, nutrigenomics, and neurodegeneration-neuroprotection by what you eat!. Mol. Neurobiol. 2013, 48:353-362.
25. Zhang X., Hong Y.-L., Xu D.-S., Feng Y., Zhao L.-J., Ruan K.-F., Yang X.-J. A review of experimental research on herbal compounds in amyotrophic lateral sclerosis. Phytother. Res. 2014, 28:9-21.
26. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
27. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol. 2009, 41:40-59.
28. Monroy A., Lithgow G.J., Alavez S. Curcumin and neurodegenerative diseases. Biofactors 2013, 39:122-132.
29. Darvesh A.S., Carroll R.T., Bishayee A., Novotny N.A., Geldenhuys W.J., Van der Schyf C.J. Curcumin and neurodegenerative diseases: a perspective. Expert Opin. Investig. Drugs 2012, 21:1123-1140.
30. Faustini M., Bucco M., Chlapanidas T., Lucconi G., Marazzi M., Tosca M.C., Gaetani P., Klinger M., Villani S., Ferretti V.V., Vigo D., Torre M.L. Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Eng. C: Methods 2010, 16:1515-1521.
31. Bruno S., Grange C., Collino F., Deregibus M.C., Cantaluppi V., Biancone L., Tetta C., Camussi G. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 2012, 7.
32. Catenacci L., Mandracchia D., Sorrenti M., Colombo L., Serra M., Tripodo G. In-solution structural considerations by 1hnmr and solid-state thermal properties of inulin-d-α-tocopherol succinate (INVITE) micelles as drug delivery systems for hydrophobic drugs. Macromol. Chem. Phys. 2014, 215:2084-2096.
33. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
34. Edetsberger M., Gaubitzer E., Valic E., Waigmann E., Kohler G. Detection of nanometer-sized particles in living cells using modern fluorescence fluctuation methods. Biochem. Biophys. Res. Commun. 2005, 332:109-116.
35. De Jong W.H., Borm P.J.A. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomed. 2008, 3:133-149.
36. Sun J., Bi C., Chan H.M., Sun S., Zhang Q., Zheng Y. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf. B: Biointerfaces 2013, 111:367-375.
37. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
38. Yu H., Huang Q. Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers. J. Agric. Food Chem. 2011, 59:9120-9126.
39. Lorenz M.R., Holzapfel V., Musyanovych A., Nothelfer K., Walther P., Frank H., Landfester K., Schrezenmeier H., Mailander V. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 2006, 27:2820-2828.
40. Dai T., Yang E., Sun Y., Zhang L., Zhang L., Shen N., Li S., Liu L., Xie Y., Wu S., Gao Z. Preparation and drug release mechanism of CTS-TAX-NP-MSCs drug delivery system. Int. J. Pharm. 2013, 456:186-194.
41. Miao T., Rao K.S., Spees J.L., Oldinski R.A. Osteogenic differentiation of human mesenchymal stem cells through alginate-graft-poly(ethylene glycol) microsphere-mediated intracellular growth factor delivery. J. Control. Release 2014, 192:57-66.
42. Rescignano N., Tarpani L., Tiribuzi R., Montesano S., Martino S., Latterini L., Maria Kenny J., Armentano I. Protein encapsulation in biodegradable polymeric nanoparticles: morphology, fluorescence behaviour and stem cell uptake. Macromol. Biosci. 2013, 13:1204-1212.
43. Hong L., Krishnamachari Y., Seabold D., Joshi V., Schneider G., Salem A.K. Intracellular release of 17-beta estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells. Tissue Eng. C: Methods 2011, 17:319-325.
44. Rejinold N.S., Muthunarayanan M., Divyarani V.V., Sreerekha P.R., Chennazhi K.P., Nair S.V., Tamura H., Jayakumar R. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J. Colloid Interface Sci. 2011, 360:39-51.
45. Li Y., Zhang T. Targeting cancer stem cells by curcumin and clinical applications. Cancer Lett. 2014, 346:197-205.
46. Dhule S.S., Penfornis P., He J., Harris M.R., Terry T., John V., Pochampally R. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma. Mol. Pharm. 2014, 11:417-427.
47. Sun X.-D., Liu X.-E., Huang D.-S. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Oncol. Rep. 2013, 29:2401-2407.
48. Gu Q., Cai Y., Huang C., Shi Q., Yang H. Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation. Pharm. Mag. 2012, 8:202-208.